茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权

新京报网2023-07-19

新京报讯据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

爱赚钱的瓜子
2023-07-19
爱赚钱的瓜子
厉害

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2352020227?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-07-19 15:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2352020227","market":"sh","top_or_hot":-1,"title":"茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权","media":"新京报网","content":"<div>\n<p>新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n茅台“酱香型白酒大曲抗菌多肽可制备抗炎药物”专利获授权\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-07-19 15:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b><strong>新京报网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0501845795.SGD","symbol_name":"瑞银大中华区股票基金P Acc SGD","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b","article_id":"2352020227","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023071915335282e0a597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2352020227","pubTimestamp":1689751920,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色葡萄球菌引起的肠道感染疾病的药物方面具有良好的应用前景。编辑 张明璇校对 翟永军","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600519":"贵州茅台","LU0501845795.SGD":"瑞银大中华区股票基金P Acc SGD","LU0577902538.SGD":"Fullerton Lux Funds - Asia Growth and Income Equities A Acc SGD","LU0577902454.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","LU0072913022.USD":"UBS (LUX) EQUITY FUND -  GREATER CHINA \"P\" (USD) ACC","BK0188":"融资融券","LU0572944931.SGD":"Janus Henderson Horizon China Opportunities A2 SGD","LU0211977185.USD":"EASTSPRING INVESTMENTS GREATER CHINA EQUITY \"A\" ACC","LU1720050803.USD":"安联全方位中国股票基金","BK0187":"一线龙头","LU0405327148.USD":"ALLSPRING CHINA A FOCUS \"A\" (USD) ACC","LU0405327494.USD":"ALLSPRING CHINA A FOCUS \"I\" (USD) ACC","LU0516423091.SGD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (SGD) ACC","LU1781817850.SGD":"Blackrock Systematic China A-Share Opportunities A2 SGD-H","LU0348825331.USD":"ALLIANZ CHINA EQUITY \"A\" (USD) INC","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK0215":"饮品","BK0175":"白马股","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU0348814723.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"A\" (USD) INC  NC","LU1580142542.USD":"Blackrock Systematic China A-Share Opportunities A2 USD","LU0878005551.USD":"UBS (LUX) KEY SELEC ASIA ALLOCATION OPPORTUNITY (USD) \"P\" (USD) ACC","BK0183":"MSCI概念","LU0594300419.USD":"富达中国消费基金A","LU1688375341.USD":"贝莱德中国灵活股票基金","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU0327786744.USD":"Janus Henderson Horizon China Opportunities A2 USD","LU0516423174.USD":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (USD) ACC","BK0012":"证金概念","BK0196":"行业龙头","LU0326950275.SGD":"Schroder ISF China Opportunities A Acc SGD-H","LU0181495838.USD":"施罗德新兴亚洲A Acc","LU1226287529.USD":"UBS (LUX) KEY SELECTION SICAV - CHINA ALLOCATION  OPPORTUNITY (USD) \"P\" (USD) ACC","LU0417516902.SGD":"Allianz China Equity Cl AT Acc SGD","LU0873338254.USD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (USD) INC","LU0651946864.USD":"贝莱德新兴市场股票收益A2","LU0918141887.USD":"安联亚洲实际收益股票基金","LU1051768304.USD":"贝莱德新兴市场股票收益A6","LU0577902371.SGD":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (SGD) ACC","LU0348816934.USD":"ALLIANZ TOTAL RETURN ASIAN EQUITY \"AT\" (USD)","LU0140636845.USD":"施罗德大中华区股票A Acc","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","BK0028":"国家队","LU0251143458.SGD":"Fidelity Emerging Markets A-SGD","LU0039217434.USD":"HSBC GIF CHINESE EQUITY \"AD\" INC","LU0650527681.SGD":"Fidelity China Consumer A-SGD","LU0577902298.EUR":"FULLERTON LUX FUNDS - ASIA GROWTH & INCOME EQUITIE \"I\" (EUR) ACC","LU0516422952.EUR":"FULLERTON LUX FUNDS - ASIA FOCUS EQUITIES \"I\" (EUR) ACC","LU0048580855.USD":"富达大中华区A"},"translate_title":"Maotai's patent \"Daqu antibacterial polypeptide of Maotai-flavor liquor can be used to prepare anti-inflammatory drugs\" was authorized","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600519":0.9},"content_text":"新京报讯 据企查查消息，贵州茅台酒股份有限公司申请的“一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用”专利近日获授权。摘要显示，该发明公开了一种酱香型白酒大曲抗菌多肽及其在制备抗炎药物中的应用，属于生物技术领域。抗菌多肽具有对革兰氏阴性菌和革兰氏阳性菌良好的抑制活性，作为天然安全的抗菌剂可作为饲料添加剂使用，也可以用于食品、化妆品或者消杀剂的制备，同时在制备预防或降低由大肠杆菌和金黄色葡萄球菌引起的肠道感染疾病的药物方面具有良好的应用前景。编辑 张明璇校对 翟永军","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":199612793843968,"gmtCreate":1689764408349,"gmtModify":1689764409850,"author":{"id":"3469825833798402","authorId":"3469825833798402","name":"爱赚钱的瓜子","avatar":"https://static.tigerbbs.com/a25f9dd9f0e446d3efad0c87609406f2","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3469825833798402","authorIdStr":"3469825833798402"},"htmlText":"厉害","listText":"厉害","text":"厉害","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/199612793843968","repostId":2352020227,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2352020227"}